Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther Gonzalez

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Journal of the American Heart Association|July 13, 2016
Automated Extracellular Volume Fraction Mapping Provides Insights Into the Pathophysiology of Left Ventricular Remodeling Post-Reperfused ST-Elevation Myocardial InfarctionHeerajnarain Bulluck, Stefania Rosmini, Amna Abdel-Gadir, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 7, 2022
Phenotype and clinical outcomes of Glu89Lys hereditary transthyretin amyloidosis: a new endemic variant in SpainFernando de Frutos, Juan Pablo Ochoa, Cristina Gómez-González, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 30, 2025
Outcomes of Patients With Extramedullary Disease in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma From the Pooled LocoMMotion and MoMMent StudiesPhilippe Moreau, María-Victoria Mateos, Hartmut Goldschmidt, et al.
The Cochrane Database of Systematic Reviews|January 19, 2026
Percutaneous coronary intervention plus guideline-directed medical therapy (GDMT) versus GDMT alone in adults with stable coronary artery diseaseArturo J Martí-Carvajal, Mark J Dayer, Diana Monge Martín, et al.
Pacing and Clinical Electrophysiology : PACE|December 6, 2023
Feasibility and safety of left bundle branch area pacing in cardiac amyloidosis. A single center experienceChinh Pham-Trung, Darwin Veloza-Urrea, Melodie Segura-Domínguez, et al.
JACC. Cardiooncology|November 29, 2022
Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure SymptomsEsther Gonzalez-Lopez, Luis Escobar-Lopez, Laura Obici, et al.
Circulation|March 31, 2026
MR-ProADM Predicts Mortality and Heart Failure Events in ATTR Cardiac AmyloidosisBelén Peiró-Aventín, Elena Revuelta-Lopez, Mariana Brandao, et al.
Heart (British Cardiac Society)|July 6, 2023
Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosisGiulia Saturi, Fernando De Frutos, Maurizio Sguazzotti, et al.
European Heart Journal|April 7, 2021
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial DiseasesPablo Garcia-Pavia, Claudio Rapezzi, Yehuda Adler, et al.
European Journal of Heart Failure|April 7, 2021
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesPablo Garcia-Pavia, Claudio Rapezzi, Yehuda Adler, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Journal of the American Heart Association|July 13, 2016
Automated Extracellular Volume Fraction Mapping Provides Insights Into the Pathophysiology of Left Ventricular Remodeling Post-Reperfused ST-Elevation Myocardial InfarctionHeerajnarain Bulluck, Stefania Rosmini, Amna Abdel-Gadir, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 7, 2022
Phenotype and clinical outcomes of Glu89Lys hereditary transthyretin amyloidosis: a new endemic variant in SpainFernando de Frutos, Juan Pablo Ochoa, Cristina Gómez-González, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 30, 2025
Outcomes of Patients With Extramedullary Disease in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma From the Pooled LocoMMotion and MoMMent StudiesPhilippe Moreau, María-Victoria Mateos, Hartmut Goldschmidt, et al.
The Cochrane Database of Systematic Reviews|January 19, 2026
Percutaneous coronary intervention plus guideline-directed medical therapy (GDMT) versus GDMT alone in adults with stable coronary artery diseaseArturo J Martí-Carvajal, Mark J Dayer, Diana Monge Martín, et al.
Pacing and Clinical Electrophysiology : PACE|December 6, 2023
Feasibility and safety of left bundle branch area pacing in cardiac amyloidosis. A single center experienceChinh Pham-Trung, Darwin Veloza-Urrea, Melodie Segura-Domínguez, et al.
JACC. Cardiooncology|November 29, 2022
Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure SymptomsEsther Gonzalez-Lopez, Luis Escobar-Lopez, Laura Obici, et al.
Circulation|March 31, 2026
MR-ProADM Predicts Mortality and Heart Failure Events in ATTR Cardiac AmyloidosisBelén Peiró-Aventín, Elena Revuelta-Lopez, Mariana Brandao, et al.
Heart (British Cardiac Society)|July 6, 2023
Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosisGiulia Saturi, Fernando De Frutos, Maurizio Sguazzotti, et al.
European Heart Journal|April 7, 2021
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial DiseasesPablo Garcia-Pavia, Claudio Rapezzi, Yehuda Adler, et al.
European Journal of Heart Failure|April 7, 2021
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesPablo Garcia-Pavia, Claudio Rapezzi, Yehuda Adler, et al.
Pageof 9